Guardant Health has helped thousands of oncologists learn accurate and actionable information about tens of thousands of patients, while avoiding the costs and risks of tissue biopsies. Our genomic test helps match advanced-cancer patients to approved targeted therapies as well as drugs in clinical trials. Guardant Health is a pioneer in non-invasive cancer diagnostics and the first company to commercialize a comprehensive genomic liquid biopsy.
Imagine a world where no one dies from cancer. At Guardant Health, you can help us build that world. Cancer is devious. It evolves to resist treatment, and it kills millions each year. If we can outsmart cancer, we believe we can beat it. That's why we need your help. Our colleagues bring expertise from across the life-sciences and technology sectors. Together, we're transforming cancer care by giving doctors and patients the information they need to fight the disease. We're excited about where our technology will take us next, and so are our investors, which include OrbiMed, Sequoia Capital, Khosla Ventures, Lightspeed Venture Partners, and Formation8. But we're most focused on the benefit our products will bring to patients. They're at the center of every decision we make.
Contact UsGuardant Health, Inc.
505 Penobscot Dr.
Redwood City, CA 94063